Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Dijkstra

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Biorxiv : the Preprint Server for Biology|August 8, 2025
MHC1-TIP enables single-tube multimodal immunopeptidome profiling and uncovers intratumoral heterogeneity in antigen presentationMayukha Bathini, Diana Bocaniciu, Fraser D Johnson, et al.
ESMO Open|April 22, 2021
Prospective experimental treatment of colorectal cancer patients based on organoid drug responsesS N Ooft, F Weeber, L Schipper, et al.
Cancer Discovery|April 10, 2021
Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and ImmunotherapyGabriele Picco, Chiara M Cattaneo, Esmée J van Vliet, et al.
Nature Genetics|October 2, 2024
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolutionClare Puttick, Thomas P Jones, Michelle M Leung, et al.
Science Translational Medicine|October 11, 2019
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patientsSalo N Ooft, Fleur Weeber, Krijn K Dijkstra, et al.
Cell|August 14, 2018
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor OrganoidsKrijn K Dijkstra, Chiara M Cattaneo, Fleur Weeber, et al.
Cancer Discovery|September 25, 2025
Microbial Metabolic Pathways Guide Response to Immune Checkpoint Blockade TherapyIris L Mimpen, Thomas W Battaglia, Miguel Parra-Martinez, et al.
Nature Medicine|April 7, 2020
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancersMyriam Chalabi, Lorenzo F Fanchi, Krijn K Dijkstra, et al.
Cancer Discovery|April 6, 2024
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung CancerKatey S S Enfield, Emma Colliver, Claudia Lee, et al.
Cancer Cell|July 4, 2025
Subclonal immune evasion in non-small cell lung cancerKrijn K Dijkstra, Roberto Vendramin, Despoina Karagianni, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Biorxiv : the Preprint Server for Biology|August 8, 2025
MHC1-TIP enables single-tube multimodal immunopeptidome profiling and uncovers intratumoral heterogeneity in antigen presentationMayukha Bathini, Diana Bocaniciu, Fraser D Johnson, et al.
ESMO Open|April 22, 2021
Prospective experimental treatment of colorectal cancer patients based on organoid drug responsesS N Ooft, F Weeber, L Schipper, et al.
Cancer Discovery|April 10, 2021
Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and ImmunotherapyGabriele Picco, Chiara M Cattaneo, Esmée J van Vliet, et al.
Nature Genetics|October 2, 2024
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolutionClare Puttick, Thomas P Jones, Michelle M Leung, et al.
Science Translational Medicine|October 11, 2019
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patientsSalo N Ooft, Fleur Weeber, Krijn K Dijkstra, et al.
Cell|August 14, 2018
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor OrganoidsKrijn K Dijkstra, Chiara M Cattaneo, Fleur Weeber, et al.
Cancer Discovery|September 25, 2025
Microbial Metabolic Pathways Guide Response to Immune Checkpoint Blockade TherapyIris L Mimpen, Thomas W Battaglia, Miguel Parra-Martinez, et al.
Nature Medicine|April 7, 2020
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancersMyriam Chalabi, Lorenzo F Fanchi, Krijn K Dijkstra, et al.
Cancer Discovery|April 6, 2024
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung CancerKatey S S Enfield, Emma Colliver, Claudia Lee, et al.
Cancer Cell|July 4, 2025
Subclonal immune evasion in non-small cell lung cancerKrijn K Dijkstra, Roberto Vendramin, Despoina Karagianni, et al.
Pageof 9